MUTYH and colorectal cancer: MUTYH monoallelic variant carriers had an approximately two-fold increased risk of colorectal cancer [39] and showed an increased risk of gastric, liver and endometrial tumors (3.34, 3.09 and 2.33, respectively) [40].